These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12894378)

  • 1. Basic principles of immunotherapy for neurologic diseases.
    Hohlfeld R; Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):121-32. PubMed ID: 12894378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmunotherapy: a practical approach to the treatment of immune-mediated neurologic diseases.
    Dalakas MC
    Semin Neurol; 1994 Jun; 14(2):97-105. PubMed ID: 7984835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulated treatment of neurologic diseases].
    Nordal HJ; Aarli JA; Nyland H; Vartdal F
    Tidsskr Nor Laegeforen; 1983 Oct; 103(30):2033-8. PubMed ID: 6658725
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of exercise on activities of daily living and quality of life: a primary care physician's perspective.
    Belfer MH
    COPD; 2007 Sep; 4(3):289-91. PubMed ID: 17729075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing face of neural stem cell therapy in neurologic diseases.
    Einstein O; Ben-Hur T
    Arch Neurol; 2008 Apr; 65(4):452-6. PubMed ID: 18413466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody therapies and neurologic disorders.
    Novak JC; Lovett-Racke AE; Racke MK
    Arch Neurol; 2008 Sep; 65(9):1162-5. PubMed ID: 18779418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive therapy in neurologic diseases and antibodies against Toxoplasma gondii].
    Cemalović-Boko Z; Cemalović-Pernar A; Richter B
    Neurologija; 1985; 34(1-4):109-20. PubMed ID: 3915344
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis.
    Maisch B; Herzum M; Schönian U
    Scand J Infect Dis Suppl; 1993; 88():149-62. PubMed ID: 8516663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy by allogeneic stem cell transplantation.
    Ringdén O
    Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentials and limitations of current and emerging immunotherapies.
    Zettl UK; Mix E
    J Neurol; 2008 Dec; 255 Suppl 6():1. PubMed ID: 19300952
    [No Abstract]   [Full Text] [Related]  

  • 12. [The strategy for immunotherapy in clinical neurological resuscitation].
    Starchenko AA; Khlunovskiĭ AN; Khil'ko VA; Prilukova TI
    Anesteziol Reanimatol; 1994; (2):64-7. PubMed ID: 8060005
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy for neurological diseases.
    Villoslada P; Moreno B; Melero I; Pablos JL; Martino G; Uccelli A; Montalban X; Avila J; Rivest S; Acarin L; Appel S; Khoury SJ; McGeer P; Ferrer I; Delgado M; Obeso J; Schwartz M
    Clin Immunol; 2008 Sep; 128(3):294-305. PubMed ID: 18534912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF antibodies: lessons from the past, roadmap for the future.
    Shealy DJ; Visvanathan S
    Handb Exp Pharmacol; 2008; (181):101-29. PubMed ID: 18071943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports.
    Novik AA; Ionova TI; Bisaga GN; Kishtovich AV; Fedorenko DA; Ivanov RA; Gorodokin GI
    Cytotherapy; 2005; 7(4):363-7. PubMed ID: 16162458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic complications of bone marrow, stem cell, and organ transplantation in patients with cancer.
    Rosenfeld MR; Pruitt A
    Semin Oncol; 2006 Jun; 33(3):352-61. PubMed ID: 16769425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive drugs in neurology].
    Cendrowski W
    Neurol Neurochir Pol; 1970; 4(6):705-9. PubMed ID: 4922589
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of physician-accompanied vacation trips for heart patients ("heart vacation trips"). Participants' satisfaction and long term impact on health related quality of life].
    Rugulies R; Krasemann EO; Siegrist J
    Rehabilitation (Stuttg); 2003 Aug; 42(4):211-7. PubMed ID: 12938043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney transplantation: determination of the problems encountered by Turkish patients and their knowledge and practices on healthy living.
    Talas MS; Bayraktar N
    J Clin Nurs; 2004 Jul; 13(5):580-8. PubMed ID: 15189411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.